Characteristic Face: A Key Indicator for Direct Diagnosis of 22q11.2 Deletions in Chinese Velocardiofacial Syndrome Patients

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Wu, Dandan ^a   Chen, Yang ^a   Xu, Chen ^a   Wang, Ke ^b   Wang, Huijun ^c   Zheng, Fengyun ^c   Ma, Duan ^c   Wang, Guomin ^a  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^b QINGDAO UNIVERSITY   (China)

^c FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BEHAVIOR DISORDER; CHILD; CHINESE; CHROMOSOME DELETION 22Q11; CHROMOSOME DELETION 22Q11.2; CHROMOSOME DUPLICATION; CHROMOSOME MAP; CLINICAL FEATURE; COGNITIVE DEFECT; CONGENITAL HEART DISEASE; CONTROLLED STUDY; FACE MALFORMATION; FEMALE; HETEROZYGOSITY; HUMAN; IMMUNE DEFICIENCY; MAJOR CLINICAL STUDY; MALE; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; PALATE MALFORMATION; PHENOTYPE; PRESCHOOL CHILD; SCHOOL CHILD; VELOCARDIOFACIAL SYNDROME;

CHILD; CHILD, PRESCHOOL; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 22; DIGEORGE SYNDROME; FEMALE; HUMANS; MALE;

EID: 84872467109     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0054404     Document Type: Article

References (40)

1. Shprintzen RJ, Goldberg RB, Lewin ML, Sidoti EJ, Berkman MD, et al. (1978) A new syndrome involving cleft palate, cardiac anomalies, typical facies, and learning disabilities: velo-cardio-facial syndrome. Cleft Palate J 15: 56-62.
2. Shprintzen RJ, (2000) Velo-cardio-facial syndrome: a distinctive behavioral phenotype. Ment Retard Dev Disabil Res Rev 6: 142-147.
3. Robin NH, Shprintzen RJ, (2005) Defining the clinical spectrum of deletion 22q11.2. J Pediatr 147: 90-96.
4. Shprintzen RJ, (2008) Velo-cardio-facial syndrome: 30 Years of study. Dev Disabil Res Rev 14: 3-10.
5. Gothelf D, Frisch A, Michaelovsky E, Weizman A, Shprintzen RJ, (2009) Velo-Cardio-Facial Syndrome. J Ment Health Res Intellect Disabil 2: 149-167.
6. Portnoï MF, (2009) Microduplication 22q11.2: a new chromosomal syndrome. Eur J Med Genet 52: 88-93.
7. Tsai CH, Van Dyke DL, Feldman GL, (1999) Child with velocardiofacial syndrome and del (4)(q34.2): another critical region associated with a velocardiofacial syndrome-like phenotype. Am J Med Genet 82: 336-339.
8. Devriendt K, De Mars K, De Cock P, Gewillig M, Fryns JP, (1995) Terminal deletion in chromosome region 8p23.1-8pter in a child with features of velo-cardio-facial syndrome. Ann Genet 38: 228-230.
9. Van Esch H, Groenen P, Fryns JP, Van de Ven W, Devriendt K, (1999) The phenotypic spectrum of the 10p deletion syndrome versus the classical DiGeorge syndrome. Genet Couns 10: 59-65.
10. Greenberg F, Courtney KB, Wessels RA, Huhta J, Carpenter RJ, et al. (1988) Prenatal diagnosis of deletion 17p13 associated with DiGeorge anomaly. Am J Med Genet 31: 1-4.
11. Friedman MA, Miletta N, Roe C, Wang D, Morrow BE, et al. (2011) Cleft palate, retrognathia and congenital heart disease in velo-cardio-facial syndrome: a phenotype correlation study. Int J Pediatr Otorhinolaryngol 75: 1167-1172.
12. Bassett AS, Chow EW, Husted J, Weksberg R, Caluseriu O, et al. (2005) Clinical features of 78 adults with 22q11 deletion syndrome. Am J Med Genet A 138: 307-313.
13. Driscoll DA, Boland T, Emanuel BS, Kirschner RE, LaRossa D, et al. (2006) Evaluation of Potential Modifiers of the Palatal Phenotype in the 22q11.2 Deletion Syndrome. Cleft Palate Craniofac J 43: 435-441.
14. McDonald-McGinn DM, Sullivan KE, (2011) Chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). Medicine (Baltimore) 90: 1-18.
15. Looman WS, Thurmes AK, O'Conner-Von SK, (2010) Quality of life among children with velocardiofacial syndrome. Cleft Palate Craniofac J 47: 273-283.
16. Kobrynski LJ, Sullivan KE, (2007) Velocardiofacial syndrome, DiGeorge syndrome: the chromosome 22q11.2 deletion syndromes. Lancet 370: 1443-1452.
17. Fernández L, Lapunzina P, Pajares IL, Palomares M, Martínez I, et al. (2008) Unrelated chromosomal anomalies found in patients with suspected 22q11.2 deletion. Am J Med Genet A 146A: 1134-1141.
18. Emanuel BS, (2008) Molecular mechanisms and diagnosis of chromosome 22q11.2 rearrangements. Dev Disabil Res Rev 14: 11-18.
19. Oh AK, Workman LA, Wong GB, (2007) Clinical correlation of chromosome 22q11.2 fluorescent in situ hybridization analysis and velocardiofacial syndrome. Cleft Palate Craniofac J 44: 62-66.
20. Rauch A, Zink S, Zweier C, Thiel CT, Koch A, et al. (2005) Systematic assessment of atypical deletions reveals genotype-phenotype correlation in 22q11.2. J Med Genet 42: 871-876.
21. Yatsenko SA, Yatsenko AN, Szigeti K, Craigen WJ, Stankiewicz P, et al. (2004) Interstitial deletion of 10p and atrial septal defect in DiGeorge 2 syndrome. Clin Genet 66: 128-136.
22. Ensenauer RE, Adeyinka A, Flynn HC, Michels VV, Lindor NM, et al. (2003) Microduplication 22q11.2, an emerging syndrome: clinical, cytogenetic, and molecular analysis of thirteen patients. Am J Hum Genet 73: 1027-1040.
23. Wentzel C, Fernström M, Ohrner Y, Annerén G, Thuresson AC, (2008) Clinical variability of the 22q11.2 duplication syndrome. Eur J Med Genet 51: 501-510.
24. Ou Z, Berg JS, Yonath H, Enciso VB, Miller DT, et al. (2008) Microduplications of 22q11.2 are frequently inherited and are associated with variable phenotypes. Genet Med 10: 267-277.
25. Lundin J, Söderhäll C, Lundén L, Hammarsjö A, White I, et al. (2010) 22q11.2 microduplication in two patients with bladder exstrophy and hearing impairment. Eur J Med Genet 53: 61-65.
26. Kitsiou-Tzeli S, Kolialexi A, Fryssira H, Galla-Voumvouraki A, Salavoura K, et al. (2004) Detection of 22q11.2 deletion among 139 patients with Di George/Velocardiofacial syndrome features. In Vivo 18: 603-608.
27. Sandrin-Garcia P, Abramides DV, Martelli LR, Ramos ES, Richieri-Costa A, et al. (2007) Typical phenotypic spectrum of velocardiofacial syndrome occurs independently of deletion size in chromosome 22q11.2. Mol Cell Biochem 303: 9-17.
28. Lipson AH, Yuille D, Angel M, Thompson PG, Vandervoord JG, et al. (1991) Velocardiofacial (Shprintzen) syndrome: an important syndrome for the dysmorphologist to recognise. Med Genet 28: 596-604.
29. Sandrin-Garcia P, Richieri-Costa A, Tajara EH, Carvalho-Salles AB, Fett-Conte AC, (2007) Fluorescence in situ hybridization (FISH) screening for the 22q11.2 deletion in patients with clinical features of velocardiofacial syndrome but without cardiac anomalies. Genet Mol Biol 30: 21-24.
30. McDonald-McGinn DM, Minugh-Purvis N, Kirschner RE, Jawad A, Tonnesen MK, et al. (2005) The 22q11.2 deletion in African-American patients: an underdiagnosed population? Am J Med Genet A 134: 242-246.
31. Xu YJ, Wang J, Xu R, Zhao PJ, Wang XK, et al. (2011) Detecting 22q11.2 deletion in Chinese children with conotruncal heart defects and single nucleotide polymorphisms in the haploid TBX1 locus. BMC Med Genet 12: 169-177.
32. Paylor R, Lindsay E, (2006) Mouse models of 22q11 deletion syndrome. Biol Psychiatry 59: 1172-1179.
33. Yagi H, Furutani Y, Hamada H, Sasaki T, Asakawa S, et al. (2003) Role of TBX1 in human del22q11.2 syndrome. Lancet 362: 1366-1373.
34. Paylor R, Glaser B, Mupo A, Ataliotis P, Spencer C, et al. (2006) Tbx1 haploinsufficiency is linked to behavioral disorders in mice and humans: implications for 22q11 deletion syndrome. Proc Natl Acad Sci USA 103: 7729-7734.
35. Zweier C, Sticht H, Aydin-Yaylagül I, Campbell CE, Rauch A, (2007) Human TBX1 missense mutations cause gain of function resulting in the same phenotype as 22q11.2 deletions. Am J Hum Genet 80: 510-517.
36. Gong W, Gottlieb S, Collins J, Blescia A, Dietz H, et al. (2001) Mutation analysis of TBX1 in non-deleted patients with features of DGS/VCFS or isolated cardiovascular defects. J Med Genet 38: E45.
37. Conti E, Grifone N, Sarkozy A, Tandoi C, Marino B, et al. (2003) DiGeorge subtypes of nonsyndromic conotruncal defects: evidence against a major role of TBX1 gene. Eur J Hum Genet 11: 349-351.
38. Scambler PJ, (2000) The 22q11 deletion syndromes. Hum Mol Genet 9: 2421-2426.
39. Vorstman JA, Jalali GR, Rappaport EF, Hacker AM, Scott C, et al. (2006) MLPA: a rapid, reliable, and sensitive method for detection and analysis of abnormalities of 22q. Hum Mutat 27: 814-821.
40. Jalali GR, Vorstman JA, Errami A, Vijzelaar R, Biegel J, et al. (2008) Detailed analysis of 22q11.2 with a high density MLPA probe set. Hum Mutat 29: 433-440.